Forest Investigative Site 0 — Jersey City, New Jersey

Forest Investigative Site 0 is a clinical research site located in Jersey City, New Jersey, United States 07311.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Forest Investigative Site 0 has participated in 1 clinical trials.

Therapeutic areas: Hypertension.

Sponsors: Forest Laboratories.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Jersey City

Browse all research sites in New Jersey · View every site in Jersey City

• CarePoint Health - Christ Hospital
• Christ Hospital- Carepoint Health
• Jersey City Medical Center
• RWJBarnabas Health Jersey City Medical Center
• New Jersey Kidney Care
• GSK Investigational Site
• Noven Pharmaceuticals
• DM Clinical Research
• Research Site
• DM Clinical Research - Jersey City
• HIS Clinical Research
• Novo Nordisk Investigational Site

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Forest Investigative Site 0?

Forest Investigative Site 0 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Forest Investigative Site 0 conducted?

Forest Investigative Site 0 has 1 clinical trials on record. Their work covers Hypertension.

Is Forest Investigative Site 0 accredited by Crixeo Clinical Trials?

Forest Investigative Site 0 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Forest Investigative Site 0?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.